Crossref journal-article
Elsevier BV
Immunity (78)
Bibliography

Caldwell, R. G., Wilson, J. B., Anderson, S. J., & Longnecker, R. (1998). Epstein-Barr Virus LMP2A Drives B Cell Development and Survival in the Absence of Normal B Cell Receptor Signals. Immunity, 9(3), 405–411.

Authors 4
  1. Robert G Caldwell (first)
  2. Joanna B Wilson (additional)
  3. Steven J Anderson (additional)
  4. Richard Longnecker (additional)
References 45 Referenced 467
  1. 10.1016/S1074-7613(00)80622-6 / Immunity / EBV persistence in memory B cells in vivo by Babcock (1998)
  2. 10.1073/pnas.94.17.9337 / Proc. Natl. Acad. Sci. USA / Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells by Braeuninger (1997)
  3. 10.1128/JVI.66.8.5161-5167.1992 / J. Virol / An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases by Burkhardt (1992)
  4. 10.1128/JVI.69.6.3752-3758.1995 / J. Virol / A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1 by Chen (1995)
  5. 10.1038/378303a0 / Nature / Syk tyrosine kinase required for mouse viability and B-cell development by Cheng (1995)
  6. 10.1073/pnas.82.9.2731 / Proc. Natl. Acad. Sci. USA / Nucleotide sequence and organization of the mouse adenine phosphoribosyltransferase gene by Dush (1985)
  7. 10.1002/j.1460-2075.1991.tb07954.x / EMBO J / Differentiation of growth signal requirement of B lymphocyte precursor is directed by expression of immunoglobulin by Era (1991)
  8. 10.1128/JVI.70.9.6216-6226.1996 / J. Virol / Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction by Fruehling (1996)
  9. 10.1006/viro.1997.8690 / Virology / The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction by Fruehling (1997)
  10. 10.1073/pnas.85.22.8693 / Proc. Natl. Acad. Sci. USA / Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation by Gratama (1988)
  11. 10.1016/S0092-8674(85)80069-6 / Cell / Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements by Grosschedl (1985)
  12. {'key': '10.1016/S1074-7613(00)80623-8_BIB12', 'series-title': 'Manipulating the Mouse Embryo', 'author': 'Hogan', 'year': '1994'} / Manipulating the Mouse Embryo by Hogan (1994)
  13. 10.1084/jem.184.4.1495 / J. Exp. Med / Hodgkin and Reed-Sternberg cells in Hodgkin’s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells by Kanzler (1996)
  14. 10.1038/309369a0 / Nature / Epstein-Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements by Katamine (1984)
  15. Kieff, E. (1996). Epstein-Barr virus and its replication. In Fundamental Virology, B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Lippincott-Raven), pp. 1109–1162.
  16. 10.1038/350423a0 / Nature / A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene by Kitamura (1991)
  17. 10.1016/S0092-8674(00)80373-6 / Cell / In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death by Lam (1997)
  18. 10.1016/0140-6736(91)90203-2 / Lancet / Circulating Epstein-Barr virus-carrying B cells in acute malaria by Lam (1991)
  19. 10.1002/ijc.2910390411 / Int. J. Cancer / Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth by Lewin (1987)
  20. 10.1128/JVI.64.5.2319-2326.1990 / J. Virol / A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1 by Longnecker (1990)
  21. 10.1016/0966-842X(96)81504-6 / Trends Microbiol / Regulation of Epstein-Barr virus latency by latent membrane protein 2 by Longnecker (1996)
  22. 10.1128/JVI.65.7.3681-3692.1991 / J. Virol / An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase by Longnecker (1991)
  23. 10.1128/JVI.66.11.6461-6469.1992 / J. Virol / The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential by Longnecker (1992)
  24. 10.1128/JVI.67.4.2006-2013.1993 / J. Virol / The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro by Longnecker (1993)
  25. 10.1128/JVI.67.8.5068-5074.1993 / J. Virol / Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B by Longnecker (1993)
  26. 10.1128/JVI.67.1.606-609.1993 / J. Virol / Marker rescue of a transformation-negative Epstein-Barr virus recombinant from an infected Burkitt lymphoma cell line by Marchini (1993)
  27. 10.1128/JVI.67.6.3087-3094.1993 / J. Virol / Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes by Miller (1993)
  28. 10.1073/pnas.91.2.772 / Proc. Natl. Acad. Sci. USA / An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking by Miller (1994)
  29. 10.1016/S1074-7613(95)80040-9 / Immunity / Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases by Miller (1995)
  30. 10.1016/0092-8674(95)90513-8 / Cell / A novel form of Epstein-Barr virus latency in normal B cells in vivo by Miyashita (1995)
  31. 10.1128/JVI.71.7.4882-4891.1997 / J. Virol / Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell by Miyashita (1997)
  32. 10.1016/0092-8674(92)90030-G / Cell / RAG-1-deficient mice have no mature B and T lymphocytes by Mombaerts (1992)
  33. 10.1128/JVI.66.6.3715-3724.1992 / J. Virol / Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes by Qu (1992)
  34. Rickinson, A.B., and Kieff, E. (1996). Epstein-Barr virus. In Fields Virology, B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Philadelphia, PA: Lippincott-Raven), pp. 2397–2446.
  35. 10.1016/0092-8674(91)90032-T / Cell / Molecular and cellular origins of B lymphocyte diversity by Rolink (1991)
  36. 10.1016/0092-8674(89)90951-3 / Cell / Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription by Schlissel (1989)
  37. 10.1084/jem.173.3.711 / J. Exp. Med / Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription by Schlissel (1991)
  38. 10.1016/0092-8674(92)90029-C / Cell / RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement by Shinkai (1992)
  39. 10.1101/gad.8.9.1030 / Genes Dev / Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice by Spanopoulou (1994)
  40. 10.4049/jimmunol.154.11.5862 / J. Immunol / Regulation of early T cell development by the engagement of TCR-β complex expressed on fetal thymocytes from TCR-β-transgenic scid mice by Takahama (1995)
  41. 10.1128/JVI.68.11.7374-7385.1994 / J. Virol / Epstein-Barr virus latency in blood mononuclear cells by Tierney (1994)
  42. 10.1038/378298a0 / Nature / Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk by Turner (1995)
  43. 10.1002/ijc.2910350107 / Int. J. Cancer / A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals by Yao (1985)
  44. 10.1002/ijc.2910430115 / Int. J. Cancer / Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers by Yao (1989)
  45. 10.1002/ijc.2910480217 / Int. J. Cancer / Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densities by Yao (1991)
Dates
Type When
Created 21 years, 2 months ago (June 11, 2004, 8:29 a.m.)
Deposited 2 years, 3 months ago (April 28, 2023, 4:59 p.m.)
Indexed 1 day, 1 hour ago (Aug. 27, 2025, 12:03 p.m.)
Issued 26 years, 11 months ago (Sept. 1, 1998)
Published 26 years, 11 months ago (Sept. 1, 1998)
Published Print 26 years, 11 months ago (Sept. 1, 1998)
Funders 0

None

@article{Caldwell_1998, title={Epstein-Barr Virus LMP2A Drives B Cell Development and Survival in the Absence of Normal B Cell Receptor Signals}, volume={9}, ISSN={1074-7613}, url={http://dx.doi.org/10.1016/s1074-7613(00)80623-8}, DOI={10.1016/s1074-7613(00)80623-8}, number={3}, journal={Immunity}, publisher={Elsevier BV}, author={Caldwell, Robert G and Wilson, Joanna B and Anderson, Steven J and Longnecker, Richard}, year={1998}, month=sep, pages={405–411} }